97 related articles for article (PubMed ID: 9122013)
1. [Tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Sep; 96(3):224-33. PubMed ID: 9122013
[TBL] [Abstract][Full Text] [Related]
2. [Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Jun; 95(6):514-23. PubMed ID: 9005420
[TBL] [Abstract][Full Text] [Related]
3. [Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Sep; 96(3):215-23. PubMed ID: 9122012
[TBL] [Abstract][Full Text] [Related]
4. [Serum level and urinary excretion of soluble Fas (sFas) in patients with primary glomerulopathies].
Kacprzyk F
Pol Arch Med Wewn; 2002 Sep; 108(3):843-7. PubMed ID: 12600180
[TBL] [Abstract][Full Text] [Related]
5. [Serum level and urinary excretion of RANTES in patients with primary glomerulonephritis].
Kacprzyk F
Pol Arch Med Wewn; 2002 Sep; 108(3):837-42. PubMed ID: 12600179
[TBL] [Abstract][Full Text] [Related]
6. [Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis].
Kacprzyk F
Pol Arch Med Wewn; 2002 Mar; 107(3):215-21. PubMed ID: 12107979
[TBL] [Abstract][Full Text] [Related]
7. In situ upregulation of IL-10 reflects the activity of human glomerulonephritides.
Niemir ZI; Ondracek M; Dworacki G; Stein H; Waldherr R; Ritz E; Otto HF
Am J Kidney Dis; 1998 Jul; 32(1):80-92. PubMed ID: 9669428
[TBL] [Abstract][Full Text] [Related]
8. Urinary tumor necrosis factor levels in primary glomerulopathies.
Ozen S; Saatci U; Tinaztepe K; Bakkaloglu A; Barut A
Nephron; 1994; 66(3):291-4. PubMed ID: 8190181
[TBL] [Abstract][Full Text] [Related]
9. Pattern of glomerular disease in Nepal: A single-center experience.
Khakurel S; Agrawal RK; Hada R
Saudi J Kidney Dis Transpl; 2015; 26(4):833-8. PubMed ID: 26178570
[TBL] [Abstract][Full Text] [Related]
10. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
Kalavrizioti D; Gerolymos M; Rodi M; Kalliakmani P; Provatopoulou S; Eleftheriadis T; Mouzaki A; Goumenos DS
Cytokine; 2015 Dec; 76(2):260-269. PubMed ID: 26307557
[TBL] [Abstract][Full Text] [Related]
11. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
Kacprzyk F
Pol Merkur Lekarski; 2003 Oct; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
[TBL] [Abstract][Full Text] [Related]
12. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
[TBL] [Abstract][Full Text] [Related]
13. Association of aldosterone synthase (CYP11B2) gene -344T/C polymorphism with the risk of primary chronic glomerulonephritis in the Polish population.
Pawlik M; Mostowska A; Lianeri M; Oko A; Jagodziński PP
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):553-8. PubMed ID: 23681285
[TBL] [Abstract][Full Text] [Related]
14. Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience.
Chang JH; Kim DK; Kim HW; Park SY; Yoo TH; Kim BS; Kang SW; Choi KH; Han DS; Jeong HJ; Lee HY
Nephrol Dial Transplant; 2009 Aug; 24(8):2406-10. PubMed ID: 19264742
[TBL] [Abstract][Full Text] [Related]
15. What is the significance of HLA-DR antigen expression in the extraglomerular mesangium in glomerulonephritis?
Gluhovschi C; Gluhovschi G; Potencz E; Lazar E; Petrica L; Bozdog G; Gadalean F; Bob F; Cioca D; Velciov S
Hum Immunol; 2012 Nov; 73(11):1098-101. PubMed ID: 22890012
[TBL] [Abstract][Full Text] [Related]
16. Increased release of tumor necrosis factor-alpha by monocytes from patients with glomerulonephritis.
Matsumoto K
Clin Nephrol; 1993 Sep; 40(3):148-54. PubMed ID: 8403569
[TBL] [Abstract][Full Text] [Related]
17. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study.
Swaminathan S; Leung N; Lager DJ; Melton LJ; Bergstralh EJ; Rohlinger A; Fervenza FC
Clin J Am Soc Nephrol; 2006 May; 1(3):483-7. PubMed ID: 17699249
[TBL] [Abstract][Full Text] [Related]
18. Cellular localization of inflammatory cytokines in human glomerulonephritis.
Takemura T; Yoshioka K; Murakami K; Akano N; Okada M; Aya N; Maki S
Virchows Arch; 1994; 424(5):459-64. PubMed ID: 8032526
[TBL] [Abstract][Full Text] [Related]
19. [The balance of proinflammatory cytokines and Treg cells in chronic glomerulonephritis].
Chebotareva NV; Vinogradov AA; Gindis AA; Bobkova IN; Cao W; Lysenko LV
Ter Arkh; 2020 Jul; 92(6):46-52. PubMed ID: 33346492
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study.
Taniguchi Y; Yorioka N; Oda H; Yamakido M
Nephron; 1996; 74(4):652-60. PubMed ID: 8956297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
